HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,265 | -33.5% | 4,015 | -15.1% | 0.00% | – |
| Q2 2023 | $25,963 | +8.2% | 4,729 | +22.8% | 0.00% | – |
| Q1 2022 | $24,000 | -11.1% | 3,851 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -15.6% | 3,851 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 3,851 | +15.6% | 0.00% | – |
| Q1 2021 | $18,000 | +28.6% | 3,330 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 3,330 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -33.3% | 3,330 | -30.4% | 0.00% | – |
| Q2 2020 | $15,000 | +50.0% | 4,782 | -8.5% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 5,226 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +35.3% | 5,226 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 5,226 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -3.6% | 5,226 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 5,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |